Literature DB >> 2493049

Immunomodulatory role of IL-4 on the secretion of Ig by human B cells.

J B Splawski1, D F Jelinek, P E Lipsky.   

Abstract

The effect of IL-4 on the production of Ig by human B cells was examined. Highly purified B cells were stimulated with Staphylococcus aureus (SA) and IL-4 alone or in combination with various other cytokines and the supernatants assayed for Ig by isotype-specific ELISA. IL-4 (10 to 100 U/ml) did not support Ig secretion by SA-stimulated blood, spleen, or lymph node B cells, whereas IL-2 supported the production of all isotypes including IgE. Moreover, IL-4 suppressed the production of all isotypes of Ig by B cells stimulated with SA and IL-2 including IgG1, IgG2, and IgE. IL-4-mediated suppression was partially reversed by IFN-gamma or -alpha and low m.w. B cell growth factor. TNF-alpha and IL-6 did not reverse the IL-4-induced suppression of Ig production. The inhibitory action of IL-4 on Ig production appeared to depend on the polyclonal activator used to stimulate the B cells. Thus, Ig secretion by B cells activated by LPS and supported by IL-2 was not inhibited by IL-4. Whereas IL-4 alone supported minimal Ig production by LPS-activated B cells, it augmented production of all Ig isotypes in cultures stimulated with LPS and supported by IL-2. IFN-gamma further enhanced production of Ig in these cultures. When the effect of IL-4 on the responsiveness of B cells preactivated with SA and IL-2 was examined, it was found not to inhibit but rather to promote Ig production modestly. A direct effect of IL-4 on the terminal differentiation of B cells was demonstrated using B lymphoblastoid cell lines. IL-4 was able to enhance the Ig secreted by an IgA-secreting hybridoma, 219 and by SKW6-CL-4, an IL-6-responsive IgM-secreting EBV transformed B cell line. These results indicate that IL-4 exerts a number of immunoregulatory actions on human B cell differentiation. It interferes with the activation of B cells by SA and IL-2, but promotes the differentiation of preactivated B cells, B cell lines, and B cells activated by LPS without apparent isotype specificity.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2493049

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  19 in total

1.  In vivo cocaine administration influences lymphokine production and humoral immune response.

Authors:  P Di Francesco; S Marini; F Pica; C Favalli; E Tubaro; E Garaci
Journal:  Immunol Res       Date:  1992       Impact factor: 2.829

2.  Cytokine regulation of immunoglobulin secretion by neonatal lymphocytes.

Authors:  J B Splawski; P E Lipsky
Journal:  J Clin Invest       Date:  1991-09       Impact factor: 14.808

3.  Delineation of the functional capacity of human neonatal lymphocytes.

Authors:  J B Splawski; D F Jelinek; P E Lipsky
Journal:  J Clin Invest       Date:  1991-02       Impact factor: 14.808

Review 4.  The role of cytokines in the pathogenesis of rheumatoid arthritis.

Authors:  P E Lipsky; L S Davis; J J Cush; N Oppenheimer-Marks
Journal:  Springer Semin Immunopathol       Date:  1989

5.  Eosinophils regulate peripheral B cell numbers in both mice and humans.

Authors:  Tina W Wong; Alfred D Doyle; James J Lee; Diane F Jelinek
Journal:  J Immunol       Date:  2014-03-10       Impact factor: 5.422

6.  Regulation of human IgG subclass production by cytokines: human IgG subclass production enhanced differentially by interleukin-6.

Authors:  Y Kawano; T Noma; K Kou; I Yoshizawa; J Yata
Journal:  Immunology       Date:  1995-02       Impact factor: 7.397

7.  IL-4 and transforming growth factor-beta suppress human immunoglobulin secretion in vitro by surface IgD- B cells.

Authors:  C Ninomiya; H L Spiegelberg
Journal:  Clin Exp Immunol       Date:  1992-08       Impact factor: 4.330

8.  Functional heterogeneity of human T cell clones from atopic and non-atopic donors.

Authors:  C A Chambers; B Zimmerman; N Hozumi
Journal:  Clin Exp Immunol       Date:  1992-04       Impact factor: 4.330

9.  IL-4 down-regulates the surface expression of CD5 on B cells and inhibits spontaneous immunoglobulin and IgM-rheumatoid factor production in patients with rheumatoid arthritis.

Authors:  T Hidaka; A Kitani; M Hara; M Harigai; K Suzuki; Y Kawaguchi; T Ishizuka; M Kawagoe; H Nakamura
Journal:  Clin Exp Immunol       Date:  1992-08       Impact factor: 4.330

10.  IL-2 enhances polyclonal IgM but not IgM-rheumatoid factor synthesis by activated human peripheral blood B cells.

Authors:  M Callaghan; A Whelan; C Feighery; B Bresnihan
Journal:  Clin Exp Immunol       Date:  1993-08       Impact factor: 4.330

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.